PARKMIM: A Transversal Pilot Study on Hemihypomimia in Parkinson Disease
Objective: To describe the prevalence of facial asymmetry due to hemihypomimia in a non fluctuating Parkinson disease (PD) cohort and compare it to age-matched controls.…The Relationship of Neuropsychiatric Symptoms and Cognitive Impairment in Parkinson’s Disease
Objective: To assess the relationship between individual items from the Neuropsychiatric Inventory and five cognitive domains in patients with Parkinson's disease (PD) and normal cognitive…Relationships of gender, care models, and neuropsychiatric symptoms in Parkinson’s disease
Objective: To examine relationships among gender, care models, and presence and management of neuropsychiatric symptoms of Parkinson’s disease (PD). Background: Neuropsychiatric symptoms such as depression…Evaluating Volume Changes in the Substantia Nigra Pars Compacta (SNc) in Parkinson’s Disease (PD) in a Study-Specific Magnetic Resonance Imaging (MRI) Template
Objective: To characterize the topography of SNc involvement in PD patients using neuromelanin (NM)-sensitive MRI (NM-MRI). Background: PD is characterized by the progressive loss of…“Brain-first” vs. “body-first” Parkinson’s disease is determined by RBD-status – a multi-modality imaging study
Objective: In a multi-modality imaging study, we test the hypothesis that Parkinson’s disease (PD) can be divided into two strikingly distinct phenotypes: (1) PD patients,…Functional Biomarkers of Parkinson’s Disease: Changes in Brain-Wide Network Connectivity in Default Mode and Fronto-Parietal Control Networks
Objective: Parkinson’s disease (PD) is a neurological disorder with no reliable biomarkers. We aimed to investigate naturalistic paradigms as functional biomarkers that distinguish between PD…Genotype influences circuit compensation in Parkinson’s disease
Objective: This study investigates differences in brain network organization in patients with Parkinson’s disease (PD) with genetic risk factors relative to sporadic PD patients and…Challenges in Parkinson’s Disease Diagnosis in a Patient with Ipsilateral Hemimelia
Objective: Our main objective is to demonstrate the challenges involved in the diagnosis of parkinsonism in a patient with transverse failure of formation of the…Stability and reliability of objective measures of speech in Parkinson’s Disease over 12 months
Objective: To describe the stability and reliability of acoustic measures of speech in Parkinson’s Disease (PD) at 3 and 12 months. Background: Speech biomarkers hold…Safinamide improves motor symptoms severity and daily living in Parkinson’s Disease (PD) patients
Objective: To evaluate the clinical effects of safinamide, administered as add-on therapy to levodopa in fluctuating PD patients, on symptoms severity and daily living. Background:…
- « Previous Page
- 1
- …
- 170
- 171
- 172
- 173
- 174
- …
- 405
- Next Page »